XML 21 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statement of Equity - USD ($)
Total
Common stock
Retained earnings (deficit)
Noncontrolling interests
Balance, Beginning of Period (in shares) at Dec. 31, 2021   14,742,754    
Balance, Beginning of Period at Dec. 31, 2021 $ 42,601,978 $ 48,452,906 $ (5,638,600) $ (212,328)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation (in shares)   162,155    
Share-based compensation 159,901 $ 159,901    
Repurchase of shares (in shares)   (174,149)    
Repurchase of common shares (566,043) $ (566,043)    
Net income (loss) (1,402,433)   (1,385,253) (17,180)
Balance, End of Period (in shares) at Mar. 31, 2022   14,730,760    
Balance, End of Period at Mar. 31, 2022 $ 40,793,403 $ 48,046,764 (7,023,853) (229,508)
Balance, Beginning of Period (in shares) at Dec. 31, 2022 14,366,316 14,366,616    
Balance, Beginning of Period at Dec. 31, 2022 $ 35,974,006 $ 47,474,973 (11,208,841) (292,126)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation (in shares)   150,260    
Share-based compensation 90,156 $ 90,156    
Repurchase of shares (in shares)   (86,829)    
Repurchase of common shares (187,961) $ (187,961)    
Net income (loss) $ 172,286   192,184 (19,898)
Balance, End of Period (in shares) at Mar. 31, 2023 14,430,047 14,430,047    
Balance, End of Period at Mar. 31, 2023 $ 36,048,487 $ 47,377,168 $ (11,016,657) $ (312,024)